MORE ABOUT THE COMPANY

Our story

Throughout the years, D&G has expanded its product portfolio into a range of therapeutic classes: anti-infectives, anti-hypertensives, anti-ulcerants, anti-allergics, mucolytics, anti-thrombotic, anti-vertigo, anti-emetic, NSAIDs, and recently, anti-neoplastic medication. Our growing client base has made it possible for us to reach a wider market in other regions of the country. 

D&G Pharma has been one of the few companies that created vibrancy in the industry by offering alternative but compelling products to better serve the Filipino market during a time when the pharmaceutical industry has been dominated by multinational companies promoting expensive products. From starting out with a few antibiotic molecules, D&G has captured the Mindanao market and established its own position as a highly reputable and dependable company. Our core principles in the company has paved the way for us to be a relevant player in the market.

Evergrowing and steadfast.

D&G Pharma came into fruition through the hard work and dedication of its founders and became a licensed and legitimate company duly acknowledged by the country’s Department of Trade and Industry in the year 2004.

Us now

Recently, D&G Pharma has introduced its three products, namely Phosvita Forte, Prozart Advance, and Pectovast MR, to Mercury Drug Corporation. Last 2017, D&G Pharma received an accreditation from Metro Pacific Hospital Holdings, Inc. The Food and Drugs Administration Philippines granted an additional License to Operate as a Food Supplements Importer and Distributor to the company for its plans to diversify its portfolio. 

D&G company aims to further widen its reach and be more competitive against leading brands in this industry by making it more accessible to the Filipino consumer. Our company strives to continue to grow and make its name as a competitive distributor in the country.